Physician profile
Jennifer Waljee
NPI 1194845834
$1,565.63
in general payments reported to CMS, 2019-2025
7 companies · $849 in 2025
The $849 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2023: $596 · 2025: $849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $500 · Education: $24.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.26 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $500.00 |
| Education | $24.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $596.32 | 2023 | |
| Stryker Corporation | $263.14 | 2025 | Variax |
| Integra Lifesciences Corporation | $212.57 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Innovation Technologies INC | $149.02 | 2025 | Irrisept |
| Djo, LLC | $134.97 | 2025 | Cmf |
| Abbvie INC. | $108.55 | 2025 | |
| Motiva USA, LLC | $101.06 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Waljee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.